Source: Neuromolecular Medicine. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, INFLAMAÇÃO, BIOMARCADORES, DOENÇAS NEURODEGENERATIVAS (FISIOPATOLOGIA), LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, v. 17, n. 3, p. 326-332, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s12017-015-8361-y. Acesso em: 05 nov. 2024.APA
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Radanovic, M., Talib, L. L., Rocha, N. P., & Gattaz, W. F. (2015). Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, 17( 3), 326-332. doi:10.1007/s12017-015-8361-yNLM
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-yVancouver
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 05 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y
